Statement Of Income

Kringle Pharma,Inc. - Filing #7290853

Concept	2023-10-01 to 2024-09-30	2023-10-01 to 2024-09-30	2023-10-01 to 2024-09-30	2023-10-01 to 2024-09-30	2022-10-01 to 2023-09-30	2022-10-01 to 2023-09-30	2022-10-01 to 2023-09-30	2022-10-01 to 2023-09-30
Statement of income
Statement of income
Net sales
Net sales	80,038,000 JPY	—	—	—	—	69,250,000 JPY	—	—
Operating revenue
Operating expenses
Cost of sales
Cost of products manufactured	JPY	—	—	—	—	JPY	—	—
Beginning finished goods inventory	JPY	—	—	—	—	JPY	—	—
Total	JPY	—	—	—	—	JPY	—	—
Ending finished goods inventory	JPY	—	—	—	—	JPY	—	—
Cost of finished goods sold	JPY	—	—	—	—	JPY	—	—
Cost of finished goods sold
Selling, general and administrative expenses	897,920,000 JPY	—	—	—	—	958,012,000 JPY	—	—
Operating expenses
Research and development expenses	643,266,000 JPY	—	—	—	—	716,792,000 JPY	—	—
Operating profit (loss)	-817,882,000 JPY	—	—	—	—	-888,762,000 JPY	—	—
Gross profit
Gross profit (loss)	80,038,000 JPY	—	—	—	—	69,250,000 JPY	—	—
Ordinary profit (loss)	-754,961,000 JPY	—	—	—	—	-852,660,000 JPY	—	—
Non-operating income
Interest income	10,000 JPY	—	—	—	—	5,000 JPY	—	—
Non-operating income
Non-operating income	62,920,000 JPY	—	—	—	—	43,431,000 JPY	—	—
Financial revenue	—	—	—	—	—	—	—	—
Other	1,000 JPY	—	—	—	—	0 JPY	—	—
Selling, general and administrative expenses
Non-operating expenses
Non-operating expenses	JPY	—	—	—	—	7,330,000 JPY	—	—
Profit (loss) before income taxes	-754,961,000 JPY	—	—	—	—	-852,660,000 JPY	—	—
Income taxes - current	1,491,000 JPY	—	—	—	—	1,490,000 JPY	—	—
Income taxes	1,491,000 JPY	—	—	—	—	1,490,000 JPY	—	—
Profit (loss)	-756,453,000 JPY	-756,453,000 JPY	-756,453,000 JPY	-756,453,000 JPY	-854,151,000 JPY	-854,151,000 JPY	-854,151,000 JPY	-854,151,000 JPY